Trademark: 86104231
Status Date
Monday, July 2, 2018
Filing Date
Tuesday, October 29, 2013
Published for Opposition
Tuesday, March 31, 2015
Abandoned Date
Monday, July 2, 2018
1 Chemical coatings used in the manufacture of medical stents; Chemical and biochemical preparations for industrial and scientific purposes, namely, polylactide, polymers and silicone
5 Chemical or pharmaceutical preparations for medical purposes, namely, polymerdrug preparations, namely, polymer-drug preparation, namely, polylactide-limus preparations, namely, drug preparations in the nature of drug delivery agents in the form of a coating that facilitate the delivery of pharmaceutical preparations; chemical or pharmaceutical preparations, namely, delivery agents in the form of a coating for medical stents that facilitate the delivery of pharmaceuticals; chemical preparations for pharmaceutical purposes, namely, a drug delivery system comprising polymer-based coatings for the release of a wide variety of therapeutic agents; chemical pharmaceutical preparations for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation; drugs, namely, paclitaxel, and limus drug family, in particular sirolimus, rapamycin, everolimus, biolimus A9, zotarolimus, tacrolimus and pimecrolimus for medical purposes for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation; surgical implants comprising living tissues ; medicines for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation for human purposes
10 Surgical and medical apparatus and instruments, namely, vascular and cardiovascular implants and apparatus in the nature of stents; coatings for medical devices or chemical or pharmaceutical preparations used for stents, namely, coatings sold as an integral component of medical stents; surgical and medical apparatus and instruments, namely, vascular and cardiovascular implants consisting of artificial materials for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation; Catheters and parts therefor, catheters for percutaneous coronary intervention (PCI), catheters for percutaneous transluminal coronary angioplasty (PTCA catheters), and catheters for percutaneous transluminal angioplasty (PTA catheters), in particular catheters for balloon dilatation; medical guidewires; medical apparatus and instruments, namely, balloons and stents and parts therefor, balloon expandable stents, self expandable stents, drug eluting stents, absorbable stents, and absorbable implantable scaffolds comprising artificial materials, coronary and peripheral balloon catheters, drug eluting balloons, drug releasing balloons, drug coated balloons
Jul 2, 2018
Abandonment Notice Mailed - No Use Statement Filed
Jul 2, 2018
Abandonment - No Use Statement Filed
Nov 29, 2017
Notice Of Approval Of Extension Request E-Mailed
Nov 28, 2017
Extension 5 Granted
Nov 21, 2017
Extension 5 Filed
Nov 27, 2017
Case Assigned To Intent To Use Paralegal
Nov 21, 2017
Teas Extension Received
Apr 8, 2017
Notice Of Approval Of Extension Request E-Mailed
Apr 5, 2017
Extension 4 Granted
Apr 5, 2017
Extension 4 Filed
Apr 5, 2017
Teas Extension Received
Nov 15, 2016
Notice Of Approval Of Extension Request E-Mailed
Nov 12, 2016
Extension 3 Granted
Oct 19, 2016
Extension 3 Filed
Oct 19, 2016
Teas Extension Received
Jun 28, 2016
Teas Change Of Correspondence Received
Apr 26, 2016
Notice Of Approval Of Extension Request E-Mailed
Apr 24, 2016
Extension 2 Granted
Mar 21, 2016
Extension 2 Filed
Apr 22, 2016
Case Assigned To Intent To Use Paralegal
Mar 21, 2016
Teas Extension Received
Mar 21, 2016
Teas Change Of Correspondence Received
Nov 17, 2015
Notice Of Approval Of Extension Request E-Mailed
Nov 13, 2015
Teas Change Of Correspondence Received
Nov 13, 2015
Extension 1 Granted
Nov 13, 2015
Extension 1 Filed
Nov 13, 2015
Teas Extension Received
Oct 2, 2015
Teas Change Of Correspondence Received
May 26, 2015
Noa E-Mailed - Sou Required From Applicant
Mar 31, 2015
Official Gazette Publication Confirmation E-Mailed
Mar 31, 2015
Published For Opposition
Mar 11, 2015
Notification Of Notice Of Publication E-Mailed
Feb 24, 2015
Law Office Publication Review Completed
Feb 21, 2015
Approved For Pub - Principal Register
Jan 31, 2015
Teas/Email Correspondence Entered
Jan 30, 2015
Correspondence Received In Law Office
Jan 30, 2015
Teas Request For Reconsideration Received
Sep 19, 2014
Notification Of Final Refusal Emailed
Sep 19, 2014
Final Refusal E-Mailed
Sep 19, 2014
Final Refusal Written
Aug 26, 2014
Teas/Email Correspondence Entered
Aug 25, 2014
Correspondence Received In Law Office
Aug 25, 2014
Teas Response To Office Action Received
Jul 15, 2014
Assigned To Examiner
Apr 10, 2014
Assigned To Examiner
Feb 25, 2014
Notification Of Non-Final Action E-Mailed
Feb 25, 2014
Non-Final Action E-Mailed
Feb 25, 2014
Non-Final Action Written
Feb 14, 2014
Assigned To Examiner
Dec 9, 2013
Applicant Amendment Prior To Examination - Entered
Dec 2, 2013
Assigned To Lie
Nov 20, 2013
Teas Voluntary Amendment Received
Nov 5, 2013
New Application Office Supplied Data Entered In Tram
Nov 1, 2013
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
